Muse Diagnostics Pvt Ltd

Based in India, Muse Diagnostics Pvt Ltd is a medical technology company specializing in innovative solutions for remote patient monitoring and telemedicine applications. Muse Diagnostics Pvt Ltd, founded in 2016 and headquartered in Bangalore, India, focuses on developing advanced medical technologies. The company raised USD 37,000 in a pre-seed funding round in June 2020 from investor Brinc. Muse Diagnostics specializes in innovative medical technology, primarily offering the TAAL digital stethoscope, designed for remote patient monitoring and telemedicine applications.

The TAAL stethoscope employs a USB-C sound output and eliminates the need for traditional buttons and Bluetooth connectivity, presenting a plug-and-play solution that operates seamlessly when connected to compatible devices. This product allows healthcare professionals to observe, edit, and share body sounds, enabling real-time consultations and secure data storage in the cloud. Additionally, the accompanying eMurmur software enhances the user experience by providing auscultation and consultation modes, high-quality audio transfer, and customizable noise cancellation features. Muse Diagnostics targets a broad customer base, including hospitals, clinics, and individual healthcare practitioners primarily in the Indian and broader Southeast Asian markets, focusing on enhancing diagnostic capabilities through advanced audio technologies.

The revenue model of Muse Diagnostics is centered around direct sales of its flagship product, the TAAL digital stethoscope, along with associated software services such as eMurmur. Transactions typically occur on a direct-to-consumer basis, where healthcare providers purchase the stethoscope and subscribe to additional software functionalities for ongoing use. Pricing structures are designed to cater to various customer segments, potentially including volume discounts for hospitals or institutional buyers. The combination of hardware sales and software subscriptions fosters a recurring revenue stream, allowing the company to generate consistent income from its clients while supporting the integration of advanced diagnostic technologies into everyday medical practice.

Muse Diagnostics is focused on expanding its product line and entering new markets. The company plans to launch upgraded versions of the TAAL stethoscope and additional telehealth products by the end of 2022. Furthermore, they aim to expand their presence in Southeast Asia and potentially into African markets by 2023. The funds raised in June 2020 will be utilized to support product development and market expansion initiatives.